Clinical Trials in Salt Lake City

Showing 5041-5060 of 12,670 trials

Study of TP-3654 in Patients With Advanced Solid Tumors

NCT03715504

TP-3654 is an oral PIM inhibitor. This is a Phase 1, open-label, dose-escalation, safety, pharmacokinetics, and pharmacodynamic study, with a purpose of determining the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of oral TP-3654 in patients with advanced solid tumors.

Advanced Solid Tumors

Sumitomo Pharma America, Inc.22 participantsStarted Apr 2019

Houston, Texas, United States • Salt Lake City, Utah, United States • Charlottesville, Virginia, United States

UNKNOWNNA< 1 mile

NGS vs Culture Outcomes for Treatment of PJI

NCT05247281

This multicenter, randomized controlled trial will compare the use of NGS and traditional culture in directing antimicrobial treatment for patients with periprosthetic joint infection.

Prosthetic Joint Infection

Center for Innovation and Research Organization250 participantsStarted Sep 2022

Los Angeles, California, United States • Weston, Florida, United States • Lebanon, New Hampshire, United States +6 more locations

COMPLETEDNA< 1 mile

SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention

NCT02779725

This project will determine the most important and cost effective components of SymptomCare@Home, a new approach to cancer chemotherapy symptom care that has been shown to reduce problematic symptoms through automated daily monitoring, self-management coaching, and oncology team follow-up care using decisional support for patients at home when their symptoms are most likely at their worse. Once the key parts of the intervention and its cost effectiveness are known, it can be moved into everyday cancer care.

Cancer

University of Utah884 participantsStarted Aug 2017

Salt Lake City, Utah, United States

Study of TP-3654 in Patients With Advanced Solid Tumors

NGS vs Culture Outcomes for Treatment of PJI

SymptomCare@Home: Deconstructing an Effective Symptom Management Intervention

Find Trials by Condition in Salt Lake City

AcQMap® US Registry of Procedural and Long-term Clinical Outcomes (Discover-US)

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa

A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the Jawline

Open-label Extension Study of Brazikumab in Ulcerative Colitis

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector

Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma

Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device)

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions

Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols

Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)

Urological and Renal Disease Engaging Adolescents in Adherence Collaborative Trial